OBJECTIVES: Natural killer (NK) cell activity is increased in individuals who remain uninfected despite repeated exposures to HIV. Given that a combined major histocompatibility complex (MHC) class I and killer immunoglobulin-like receptor (KIR) KIR3D genotype has been linked to rate of HIV disease progression, we assessed whether these genotypes played a role in protection from infection. DESIGN: The study genotyped 80 HIV-exposed uninfected (EU) and 304 subjects in HIV primary infection (PI) at the MHC class IB and KIR3DS/L1 loci. METHODS: KIR3D genotyping was performed by sequence-specific primer polymerase chain reaction using two pairs of specific primers for each locus. The MHC class IB locus was typed by sequence-specific oligonucleotide polymerase chain reaction and sequencing to resolve Bw4 and Bw6 alleles and the amino acid present at position 80. RESULTS: Comparison of the genetic distribution of KIR3D, HLA Bw4 and HLA Bw4-I80 genotypes in EU versus PI subjects reveal an increased proportion of KIR3DS1 homozygotes in EU (11/80, 13.8%) compared to subjects in PI (16/304, 5.3%). Analyses of combined MHC class I and KIR3D expression show no differences between the two populations. CONCLUSIONS: Homozygosity for the activating NK receptor KIR3DS1, may contribute to the more active NK cell function observed in EU and their relative resistance to HIV infection.
OBJECTIVES: Natural killer (NK) cell activity is increased in individuals who remain uninfected despite repeated exposures to HIV. Given that a combined major histocompatibility complex (MHC) class I and killer immunoglobulin-like receptor (KIR) KIR3D genotype has been linked to rate of HIV disease progression, we assessed whether these genotypes played a role in protection from infection. DESIGN: The study genotyped 80 HIV-exposed uninfected (EU) and 304 subjects in HIV primary infection (PI) at the MHC class IB and KIR3DS/L1 loci. METHODS: KIR3D genotyping was performed by sequence-specific primer polymerase chain reaction using two pairs of specific primers for each locus. The MHC class IB locus was typed by sequence-specific oligonucleotide polymerase chain reaction and sequencing to resolve Bw4 and Bw6 alleles and the amino acid present at position 80. RESULTS: Comparison of the genetic distribution of KIR3D, HLA Bw4 and HLA Bw4-I80 genotypes in EU versus PI subjects reveal an increased proportion of KIR3DS1 homozygotes in EU (11/80, 13.8%) compared to subjects in PI (16/304, 5.3%). Analyses of combined MHC class I and KIR3D expression show no differences between the two populations. CONCLUSIONS: Homozygosity for the activating NK receptor KIR3DS1, may contribute to the more active NK cell function observed in EU and their relative resistance to HIV infection.
Authors: Costin Tomescu; Fuh-Mei Duh; Michael A Lanier; Angela Kapalko; Karam C Mounzer; Maureen P Martin; Mary Carrington; David S Metzger; Luis J Montaner Journal: AIDS Date: 2010-09-10 Impact factor: 4.177
Authors: Nicolas Zucchini; Karine Crozat; Thomas Baranek; Scott H Robbins; Marcus Altfeld; Marc Dalod Journal: Expert Rev Anti Infect Ther Date: 2008-12 Impact factor: 5.091
Authors: Rebecca N Koehler; Galit Alter; Sodsai Tovanabutra; Elmar Saathoff; Miguel A Arroyo; Anne M Walsh; Eric E Sanders-Buell; Leonard Maboko; Michael Hoelscher; Merlin L Robb; Nelson L Michael; Francine E McCutchan; Jerome H Kim; Gustavo H Kijak Journal: J Infect Dis Date: 2013-08-06 Impact factor: 5.226
Authors: C-C Tang; G Isitman; J Bruneau; C Tremblay; N F Bernard; S J Kent; M S Parsons Journal: Clin Exp Immunol Date: 2015-06-07 Impact factor: 4.330
Authors: Christopher W Pohlmeyer; Veronica D Gonzalez; Alivelu Irrinki; Ricardo N Ramirez; Li Li; Andrew Mulato; Jeffrey P Murry; Aaron Arvey; Rebecca Hoh; Steven G Deeks; George Kukolj; Tomas Cihlar; Stefan Pflanz; Garry P Nolan; Gundula Min-Oo Journal: J Virol Date: 2019-03-21 Impact factor: 5.103
Authors: Bojana Durovic; Olivier Gasser; Patrick Gubser; Jörg Sigle; Hans H Hirsch; Martin Stern; Andreas Buser; Christoph Hess Journal: J Virol Date: 2013-03-27 Impact factor: 5.103
Authors: Aniqa Shahid; Denis R Chopera; Eric Martin; Kali A Penney; M-J Milloy; Zabrina L Brumme Journal: J Immunol Methods Date: 2013-03-21 Impact factor: 2.303